:: Class Utilisation Summary 2017
See LEGEND for key to shading and symbols.
:: Subject Area - PHAR Term - Semester 1
| PHAR3102 | PHAR3111 | PHAR3251 | PHAR9101 | PHAR9113 | PHAR9114 |
| PHAR9116 | PHAR9118 | PHAR9122 | PHAR9124 |
Data is correct as at Sunday 8 October 19:07:09 AEDT 2017
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| PHAR3102 | Molecular Pharmacology | ||||||
| LAB | H10A | 7086 | Enr | Open | 34/40 | 85% | Thu 10-13 (Wurth 120) |
| LAB | H14A | 7087 | Enr | Open | 33/40 | 83% | Thu 14-17 (Wurth 120) |
| LEC | A | 7085 | Rel | Open | 67/80 | 84% | Tue 09 (MathewsThD); Wed 13 (WurthLG03) |
| TUT | W09A | 7089 | Rel | Open | 28/40 | 70% | Wed 09 (WurthLG03) |
| TUT | W14A | 7088 | Rel | Open | 39/40 | 98% | Wed 14 (MorvB G6) |
| PHAR3111 | Clinical Pharmacology for HESC | ||||||
| LAB | M09A | 9225 | Rel | Open | 90/94 | 96% | Mon 09-12 (w3,5,9,11, Wurth 115); Mon 09-12 (w7, Wurth 115) |
| LE1 | A | 9223 | Auto | Open | 90/94 | 96% | Wed 16-18 (WurthLG03) |
| LE2 | B | 9224 | Rel | Open | 90/94 | 96% | Mon 14 (w2,4,6,8,10,12, MathewsThD) |
| TUT | M14A | 9226 | Enr | Open | 46/47 | 98% | Mon 14 (w1,3,5,7,9,11, Mat 230) |
| TUT | M15A | 9227 | Enr | Open | 44/47 | 94% | Mon 15 (w1, Mat 230); Mon 15 (w3,5,7,9,11, Mat 230) |
| PHAR3251 | Clinical & Exp'l Pharmacology | ||||||
| LAB | T10A | 4244 | Enr | Full | 80/80 | 100% | Tue 10-13 (w1-3,5-6,8-12, Wurth 120); Tue 10-13 (w4,7, WurthG06) |
| LEC | A | 4243 | Rel | Full* | 80/80 | 100% | Mon 13 (CivEng G1); Fri 12 (CLB 1) |
| TUT | T13A | 4245 | Rel | Full | 40/40 | 100% | Tue 13 (w2-7,8-13, Mat 102) |
| TUT | T14A | 4246 | Rel | Full | 40/40 | 100% | Tue 14 (w2-7,8-13, Mat 102) |
| PHAR9101 | Intro to Therapeutics Industry | ||||||
| DST | DIST | 10386 | Enr | Open | 22/30 | 73% | |
| PHAR9113 | InternationalRegulatoryAffairs | ||||||
| DST | DIST | 10388 | Enr | Open | 5/20 | 25% | |
| PHAR9114 | HTA in Australia | ||||||
| DST | DIST | 10389 | Enr | Open | 11/25 | 44% | |
| PHAR9116 | Clinical Trial Management | ||||||
| DST | DIST | 10405 | Enr | Open | 0/10 | 0% | |
| PHAR9118 | Therapeutics | ||||||
| DST | DIST | 10390 | Enr | Open | 0/20 | 0% | |
| PHAR9122 | Medical Affairs | ||||||
| DST | DIST | 10406 | Enr | Open | 27/50 | 54% | |
| PHAR9124 | Internship | ||||||
| DST | DIST | 10407 | Enr | Open* | 0/5 | 0% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G • Authorised by Deputy Vice Chancellor (Academic) & Registrar • Privacy Statement • Copyright & Disclaimer |